Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus

Vaccine

Volumn 17, Issue 11-12, 1999, Pages 1573-1580

  McNeal, Monica M ^a   Rae, Mary N ^a   Ward, Richard L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Adjuvants; Intramuscular immunization; Rotavirus

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INACTIVATED VACCINE; POLY[DI(CARBOXYLATOPHENOXY)PHOSPHAZENE]; QS 21; QS 7; QUIL A; RIBI ADJUVANT; ROTAVIRUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; INFECTION PREVENTION; INTERMETHOD COMPARISON; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; ROTAVIRUS; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS SHEDDING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; FEMALE; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; ROTAVIRUS; ROTAVIRUS INFECTIONS; SAPONINS; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 0033577259     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00359-4     Document Type: Article

References (28)

1. De-Mol P., Zissis G., Butzler J.P., Mutwewingabo A., Andre F.E. Failure of live, attenuated oral rotavirus vaccine. Lancet. ii:1986;108.
2. Christy C., Madore H.P., Pichichero M.E., Gala C., Pincus P., Vosefski D., Hoshino Y., Kapikian A., Dolin R. Field trial of rhesus rotavirus vaccine in infants. Pediatr Infect Dis J. 7:1988;645-650.
3. Bernstein D.I., Smith V.E., Sander D.S., Pax K.A., Schiff G.M., Ward R.L. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants. J Infect Dis. 162:1990;1055-1062.
4. Bernstein D.I., Glass R.I., Rodgers G., Sack D.A. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. J Am Med Assoc. 273:1995;1191-1196.
5. Santosham M., Letson G.W., Wolfe M., Reid R., Gahagan S., Adams R., Callahan C., Sack R.B., Kapikian A.Z. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis. 163:1991;483-487.
6. Santosham M., Moulton L.H., Reid R., Croll J., Weatherbolt R., Ward R.L., Forro J., Zito E., Mack M., Brenneman G., Davidson B.L. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr. 131:1997;632-638.
7. QHBRV Study Group, Clark H.F., White C.J., Offit P.A., Stinson D., Eiden J., Weaver S., Cho I., Shaw A., Krah D., Ellis R. Preliminary evaluation of safety and efficacy of quadrivalent human-bovine reassortant rotavirus vaccine (QHBRV). Pediatr Res. 37:1995;1016.
8. Rennels M.B., Glass R.I., Dennehy P.H., Bernstein D.I., Pichichero M.E., Zito E.T., Mack M.E., Davidson B.L., Kapikian A.Z. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines - Report of the National Multicenter Trial. Pediatrics. 97:1996;7-13.
9. Lanata C.F., Midthun K., Black R.E., Butron B., Huapaya A., Penny M.E., Ventura G., Gil A., Jett-Goheen M., Davidson B.L. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima. Peru J Infect Dis. 174:1996;268-275.
10. Ward R.L., McNeal M.M., Sheridan J.F. Development of an adult mouse model for studies on protection against rotavirus. J Virol. 64:1990;5070-5075.
11. McNeal M.M., Sheridan J.F., Ward R.L. Active protection against rotavirus infection of mice following intraperitoneal immunization. Virology. 191:1992;150-157.
12. Conner M.E., Crawford S.E., Barone C., Estes M.K. Rotavirus vaccine administered parenterally induces protective immunity. J Virol. 67:1993;6633-6641.
13. Coffin S.E., Moser C.A., Cohen S., Clark H.F., Offit P.A. Immunologic correlates of protection against rotavirus challenge after intramuscular immunization of mice. J Virol. 71:1997;7851-7856.
14. McNeal M.M., Rae M.N., Conner M.E., Ward R.L. Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21. Virology. 243:1998;158-166.
15. Yuan L., Kang S.-Y., Ward L.A., To T.L., Saif L.J. Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus. J Virol. 72:1998;330-338.
16. Kensil C.R. Saponins as vaccine adjuvants. Crit Rev Therap Drug Carrier Systems. 13:1996;1-55.
17. Ulrich JT, Myers KR. Monophosphoryl lipid A as an adjuvant. In: Powell MF, Newman MJ, editors. Vaccine design: the subunit and adjuvant approach. New York, NY: Plenum Press, 1995. p. 495-524.
18. Kensil CR, Wu J-Y, Anderson CA, Wheeler DA, Amsden J. QS-21 and QS-7: purified saponin adjuvants. In: Brown F, Haaheim LR, editors. Modulation of the immune response to vaccine antigens. Dev. Biol. Stand. Basel: Karger, 1998. p. 41-47.
19. Payne L.G., Jenkins S.A., Woods A.L., Grund E.M., Geribo W.E., Loebelenz J.R., Andrianov A.K.et al. Poly [di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine. Vaccine. 16:1998;92-98.
20. McNeal M.M., Broome R.L., Ward R.L. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination. Virology. 204:1994;642-650.
21. 8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology. 214:1995;387-397.
22. Knowlton D.R., Spector D.M., Ward R.L. Development of an improved method for measuring neutralizing antibody to rotavirus. J Virol Meth. 33:1991;127-134.
23. Mosmann T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 7:1989;145-174.
24. Offit PA, Rotaviruses: immunological determinants of protection against infection and disease. In: Maramorosch K, Murphy FA, Shatkin AJ, editors. Advances in virus research. San Diego, CA: Academic Press, Inc., 1994. p. 161-202.
25. Payne LG, Van Nest GA, Barchfeld GL, Siber GR, Gupta RK, Jenkins SA. PCPP as a parenteral adjuvant for diverse antigens. In: Brown F, Haaheim LR, editors. Modulation of the immune response to vaccine antigens. Dev. Biol. Stand., Basel: Karger, 1998. p. 79-87.
26. Barr I.G., Mitchell G.F. ISCOMs (immunostimulating complexes): The first decade. Immunol Cell Biol. 74:1996;8-25.
27. McNeal M.M., Ward R.L. Long-term production of rotavirus antibody and protection against reinfection following a single infection of neonatal mice with murine rotavirus. Virology. 211:1995;474-480.
28. Franco M.A., Greenberg H.B. Role of B cells and cytotoxic T lymphocytes in clearance of an immunity to rotavirus infection in mice. J Virol. 69:1995;7800-7806.